Antimicrobial activity of novel N-quinolinyl and N-naphthylimino-1,2,3-dithiazoles

European Journal of Medicinal Chemistry

Volumn 33, Issue 2, 1998, Pages 149-153

  Thiéry, Valérie ^a   Rees, Charles W ^b   Besson, Thierry ^a   Cottenceau, Gilles ^a   Pons, Anne Marie ^a  

^a UNIVERSITÉ DE LA ROCHELLE   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antimicrobial activity; Imino 1,2,3 dithiazoles; Quinolines

Indexed keywords

1,2,3 DITHIAZOLE DERIVATIVE; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; FLUCONAZOLE; FLUCYTOSINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; DRUG SYNTHESIS; FUNGICIDAL ACTIVITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; YEAST;

EID: 0032007215     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(98)80040-8     Document Type: Article

References (10)

1. [1] The salt 1 is a pale greenish yellow solid, insoluble in organic solvents. It is completely stable in a dry inert atmosphere but reacts slowly with moisture to form 4-chloro-1,2,3-dithiazol-5-one: Appel R., Janssen H., Siray M., Knoch F., Chem. Ber. 118 (1985) 1632-1643.
2. [2] Rees CW., J. Heterocycl. Chem. 29 (1992) 639-651.
3. [3] Besson T., Rees CW., J. Chem. Soc. Perkin Trans. 1 (1995) 1659-1662.
4. [4] Moore J.E., US Pat., 4 059 590/1977 [Chem. Abstr. 88 (1978) 50874].
5. [5] Mayer R., Förster E., Matauschek B.D., German Pat., DD 212 387/1984 [Chem. Abstr. 102 (1985) 113064].
6. [6] Cottenceau G., Besson T., Gautier V., Rees C.W., Pons A.M., Bioorg. Med. Chem. Lett. 6 (1996) 529-532.
7. [7] Rees C.W., Roe D.G., Thiéry V., Chem. Commun. (1996) 2775-2776.
8. [8] Barry A.L., Thornsberry C., Susceptibility tests: Diffusion test procedures. In: Balows A., Hausler W.J., Herrmann Jr K.L., Isenberg H.D., Shadomy H.J. (Eds.), Manual of Clinical Microbiology, 5th ed., American Society for Microbiology, Washington DC, 1991, pp. 1117-1125.
9. [9] Shadomy S., Pfaller M.A., Laboratory studies with antifungal agents: susceptibility tests and quantification in body fluids. In: Balows A., Hausler W.J., Herrmann Jr K.L., Isenberg H.D., Shadomy H.J. (Eds.), Manual of Clinical Microbiology, 5th ed., American Society for Microbiology, Washington DC, 1991, pp. 1173-1183.
10. [10] Sahm D.F., Washington J.A., Antibacterial susceptibility tests: Dilution methods. In: Balows A., Hausler W.J., Herrmann Jr K.L., Isenberg H.D., Shadomy H.J. (Eds.), Manual of Clinical Microbiology, 5th ed., American Society for Microbiology, Washington DC, 1991, pp. 1105-1116.